SCHEMBL6760737

SCHEMBL6760737

COc1ccc2[nH]c(SCCN3CCN(CC(=O)Nc4c(SC)cc(C)nc4SC)CC3)nc2c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 8/20 0.79
ALDH1A1 P00352 4/20 0.44
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 2/20 0.41
FPR1 P21462 1/20 0.41
FPR2 P25090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6760738 0.94 SOAT1 (0.78) SOAT1ALDH1A1CYP1A2CYP2E1CYP2C8
SCHEMBL6279700 0.90 SOAT1 (0.84) SOAT1ALDH1A1TSHRNPC1RAB9A
SCHEMBL4836774 0.89 SOAT1 (0.77) SOAT1ALDH1A1TSHRKDM4EHPGD
SCHEMBL960484 0.89 SOAT1 (1.00) SOAT1ALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL29845569 0.89 SOAT1 (1.00) SOAT1ALDH1A1TSHRCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL6283825 0.88 SOAT1 (1.00) SOAT1ALDH1A1TSHRCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL29972967 0.88 SOAT1 (1.00) SOAT1ALDH1A1TSHRCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL1704627 0.88 SOAT1 (1.00) SOAT1ALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL6279708 0.86 SOAT1 (0.83) SOAT1ALDH1A1TSHRUSP2NPC1
SCHEMBL4836791 0.84 SOAT1 (0.76) SOAT1ALDH1A1TSHRCYP2E1CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same LCAT, ACAT2, ACAT1 SOAT1 5/4885ALDH1A1 307/4885TSHR 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.